Investor Alta Partners VIII, L.P.
13D/G Filings

This page shows a list of all the recent 13D/G filings made by Alta Partners VIII, L.P. . Schedule 13D is commonly referred to as a “beneficial ownership report.” The term "beneficial owner" is defined under SEC rules. It includes any person who directly or indirectly shares voting power or investment power (the power to sell the security).

When a person or group of persons acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities, they are required to file a Schedule 13D within ten days after the purchase. Click the link icon to see the full transaction history.

Add This Fund
to your dashboard

Date Form Target Prev
Shares		 Current
Shares		 Change
(Percent)		 Ownership
(Percent)		 Change
(Percent)
2023-08-18 13D/A ALLK / Allakos Inc. 8,672,437 3,037,955
2021-02-16 13G/A STRO / Sutro Biopharma, Inc. 1,948,516 0
2021-01-06 13D/A ALLK / Allakos Inc. 10,551,627 8,672,437
2020-01-28 13D/A ALLK / Allakos Inc. 11,521,289 10,551,627
2020-01-14 13G/A LIFE / aTyr Pharma, Inc. 1,590,920 0
2019-02-12 13G STRO / Sutro Biopharma, Inc. 1,948,516
2019-02-12 13G/A LIFE / aTyr Pharma, Inc. 1,777,875 1,590,920
2018-11-08 13D/A TRVN / Trevena, Inc. 2,890,262
2018-08-02 13D ALLK / Allakos Inc. 11,521,289
2018-05-31 13D/A AGTC / Applied Genetic Technologies Corp 1,141,987 51,896
2018-02-06 13G/A LIFE / aTyr Pharma, Inc. 1,778,064 1,777,875
2017-12-29 13D/A ESPR / Esperion Therapeutics, Inc. 1,472,695 712,161
2017-03-27 13D/A ESPR / Esperion Therapeutics, Inc. 1,472,695
2017-02-08 13G/A EVFM / Evofem Biosciences, Inc. 1,198,195 213,017
2016-02-12 13G/A LRMR / Larimar Therapeutics, Inc. 0
2016-02-12 13G LIFE / aTyr Pharma, Inc. 1,778,064
2016-02-12 13G/A KITE / Kite Pharma, Inc. 1,820,790
2016-02-12 13G/A EVFM / Evofem Biosciences, Inc. 1,198,195
2015-06-09 13D/A ZSPH / ZS Pharma, Inc. 2,933,667 2,646,643
2015-06-03 13D/A ZSPH / ZS Pharma, Inc. 2,933,667
2015-04-20 13D/A AGTC / Applied Genetic Technologies Corp 1,141,987
2015-02-20 13D/A CMRX / Chimerix, Inc. 1,809,695
2015-02-12 13G LRMR / Larimar Therapeutics, Inc. 1,164,329
2015-02-12 13G KITE / Kite Pharma, Inc. 2,944,114
2015-02-12 13G EVFM / Evofem Biosciences, Inc. 2,667,024
2014-12-15 13D/A TRVN / Trevena, Inc. 4,390,262
2014-11-19 13D/A AGTC / Applied Genetic Technologies Corp 1,504,636
2014-10-22 13D/A CMRX / Chimerix, Inc. 2,644,897
2014-08-08 13D IMDZ / Immune Design Corp. 2,482,775
2014-07-03 13D ZSPH / ZS Pharma, Inc. 3,230,090
2014-04-11 13D AGTC / Applied Genetic Technologies Corp 2,984,400
2014-02-18 13D TRVN / Trevena, Inc. 3,890,262
2013-07-11 13D CMRX / Chimerix, Inc. 2,144,897